| An Essential role for DeltaFosB in the median preoptic nucleus in the sustained hypertensive effects of chronic intermittent hypoxia. | |
| | |
MedLine Citation:
|
PMID: 22689746 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
One of the main clinical features of obstructive sleep apnea is sustained hypertension and elevated sympathetic activity during waking hours. Chronic intermittent hypoxia (CIH), animal model of the hypoxemia associated with obstructive sleep apnea, produces a similar sustained increase in blood pressure. This study determined the role of ΔFosB in the median preoptic nucleus (MnPO) in the sustained increase in mean arterial pressure associated with CIH. Rats were injected in the MnPO with viral vectors that expressed green fluorescent protein alone or green fluorescent protein plus a dominant-negative construct that inhibits the transcriptional effects of ΔFosB. In green fluorescent protein-injected rats and uninjected controls, 7-day exposure to CIH increased mean arterial pressure by 7 to 10 mm Hg during both intermittent hypoxia exposure and normoxia. Dominant-negative inhibition of MnPO ΔFosB did not affect changes in mean arterial pressure during intermittent hypoxia exposure but significantly reduced the sustained component of the blood pressure response to CIH during the normoxic dark phase. Inhibition of MnPO ΔFosB reduced the FosB/ΔFosB staining in the paraventricular nucleus and rostral ventrolateral medulla but not the nucleus of the solitary tract. PCR array analysis identified 6 activator protein 1-regulated genes expressed in the MnPO that were increased by CIH exposure, ace, ace2, nos1, nos3, prdx2, and map3k3. Dominant-negative inhibition of ΔFosB in the MnPO blocked increased expression of each of these genes in rats exposed to CIH except for Prdx2. ΔFosB may mediate transcriptional activity in MnPO necessary for sustained CIH hypertension, suggesting that neural adaptations may contribute to diurnal hypertension in obstructive sleep apnea. |
| | |
Authors:
|
J Thomas Cunningham; W David Knight; Steven W Mifflin; Eric J Nestler |
Related Documents
:
|
18307736 - Advances in reducing the burden of vascular disease in type 2 diabetes. 6826936 - Achievements in hypertension: a 25 year overview. 2246036 - Effect of age on the efficacy of blood pressure treatment strategies. 20167156 - Blood pressure 2 years after a chronic disease management intervention study. 3753076 - Prevention of reperfusion injury of the ischemic spinal cord: use of recombinant supero... 11247796 - Human cardiac myosin heavy chain isoforms in fetal and failing adult atria and ventricles. |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Extramural Date: 2012-06-11 |
Journal Detail:
|
Title: Hypertension Volume: 60 ISSN: 1524-4563 ISO Abbreviation: Hypertension Publication Date: 2012 Jul |
Date Detail:
|
Created Date: 2012-06-15 Completed Date: 2012-09-07 Revised Date: 2013-04-16 |
Medline Journal Info:
|
Nlm Unique ID: 7906255 Medline TA: Hypertension Country: United States |
Other Details:
|
Languages: eng Pagination: 179-87 Citation Subset: IM |
Affiliation:
|
Department of Integrative Physiology, University of North Texas Health Science Center at Fort Worth, 3500 Camp Bowie Blvd, Fort Worth, TX 76107, USA. Tom.Cunningham@unthsc.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Anoxia / genetics, metabolism, physiopathology* Chronic Disease Dependovirus / genetics Gene Expression Profiling Genetic Vectors / genetics Green Fluorescent Proteins / genetics, metabolism Heart Rate / genetics, physiology Hypertension / genetics, physiopathology* Immunohistochemistry Male Microscopy, Fluorescence Nitric Oxide Synthase Type I / genetics Nitric Oxide Synthase Type III / genetics Oligonucleotide Array Sequence Analysis Peptidyl-Dipeptidase A / genetics Peroxiredoxins / genetics Preoptic Area / metabolism, physiopathology* Proto-Oncogene Proteins c-fos / genetics, metabolism, physiology* Rats Rats, Sprague-Dawley Reverse Transcriptase Polymerase Chain Reaction Transduction, Genetic |
| Grant Support | |
ID/Acronym/Agency:
|
P01HL-88052/HL/NHLBI NIH HHS; R01 HL062579/HL/NHLBI NIH HHS; R01 MH-51399/MH/NIMH NIH HHS; R01 MH051399/MH/NIMH NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Fosb protein, rat; 0/Proto-Oncogene Proteins c-fos; 147336-22-9/Green Fluorescent Proteins; EC 1.11.1.15/PRDX2 protein, human; EC 1.11.1.15/Peroxiredoxins; EC 1.14.13.39/Nitric Oxide Synthase Type I; EC 1.14.13.39/Nitric Oxide Synthase Type III; EC 1.14.13.39/Nos1 protein, rat; EC 1.14.13.39/Nos3 protein, rat; EC 3.4.15.1/Peptidyl-Dipeptidase A; EC 3.4.17.-/angiotensin converting enzyme 2 |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Chronic matrix metalloproteinase inhibition retards age-associated arterial proinflammation and incr...
Next Document: Endothelin 1-dependent neurovascular dysfunction in chronic intermittent hypoxia.